Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Robbins LLP is Investigating Allegations that Gartner, Inc. (IT) Misled Investors Regarding its Growth and Projected Revenue
-
Robbins LLP is Investigating Allegations that Alight, Inc. (ALIT) Misled Investors Regarding its Potential Growth and Financial Stability
-
Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in light of its Monopoly
-
Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved
-
Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
-
Robbins LLP is Investigating Allegations that Eos Energy Enterprises, Inc. (EOSE) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Ostin Technology Group Co., Ltd. (OST) Engaged in a Pump-and-Dump Scheme that Defrauded Investors
-
Robbins LLP is Investigating Allegations that Enphase Energy, Inc. (ENPH) Misled Investors Regarding its Ability to Manage its Channel Inventory
-
Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
-
Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies